211 related articles for article (PubMed ID: 20799467)
1. Different immunotherapy applications--different mechanisms? SLIT versus SCIT--differences in the mode of action.
Allam JP; Bieber T; Novak N
Arb Paul Ehrlich Inst Bundesinstitut Impfstoffe Biomed Arzneim Langen Hess; 2009; 96():237-40; discussion 240-5. PubMed ID: 20799467
[No Abstract] [Full Text] [Related]
2. Immune mechanisms of allergen-specific sublingual immunotherapy.
Moingeon P; Batard T; Fadel R; Frati F; Sieber J; Van Overtvelt L
Allergy; 2006 Feb; 61(2):151-65. PubMed ID: 16409190
[TBL] [Abstract][Full Text] [Related]
3. A novel approach in allergen-specific immunotherapy: combination of sublingual and subcutaneous routes.
Keles S; Karakoc-Aydiner E; Ozen A; Izgi AG; Tevetoglu A; Akkoc T; Bahceciler NN; Barlan I
J Allergy Clin Immunol; 2011 Oct; 128(4):808-815.e7. PubMed ID: 21641635
[TBL] [Abstract][Full Text] [Related]
4. Local immunological mechanisms of sublingual immunotherapy.
Allam JP; Novak N
Curr Opin Allergy Clin Immunol; 2011 Dec; 11(6):571-8. PubMed ID: 22001742
[TBL] [Abstract][Full Text] [Related]
5. Sublingual immunotherapy mechanisms of action: the role of Th1 response.
Ciprandi G; Tosca MA; Marseglia GL
Int J Immunopathol Pharmacol; 2009; 22(4 Suppl):9-12. PubMed ID: 19944003
[TBL] [Abstract][Full Text] [Related]
6. Immunological mechanisms of sublingual allergen-specific immunotherapy.
Novak N; Bieber T; Allam JP
Allergy; 2011 Jun; 66(6):733-9. PubMed ID: 21251016
[TBL] [Abstract][Full Text] [Related]
7. Two year follow-up of immunological response in mite-allergic children treated with sublingual immunotherapy. Comparison with subcutaneous administration.
Antúnez C; Mayorga C; Corzo JL; Jurado A; Torres MJ
Pediatr Allergy Immunol; 2008 May; 19(3):210-8. PubMed ID: 18399897
[TBL] [Abstract][Full Text] [Related]
8. Sublingual allergen immunotherapy: mode of action and its relationship with the safety profile.
Calderón MA; Simons FE; Malling HJ; Lockey RF; Moingeon P; Demoly P
Allergy; 2012 Mar; 67(3):302-11. PubMed ID: 22150126
[TBL] [Abstract][Full Text] [Related]
9. Specific immunotherapy by different allergen applications: subcutaneous, sublingual, oral or rectal administration and lymph node injection.
Kleine-Tebbe J
Arb Paul Ehrlich Inst Bundesinstitut Impfstoffe Biomed Arzneim Langen Hess; 2009; 96():87-95; discussion 95. PubMed ID: 20799448
[No Abstract] [Full Text] [Related]
10. Dendritic cells in allergen-specific immunotherapy.
Novak N
Drugs Today (Barc); 2008 Dec; 44 Suppl B():91-2. PubMed ID: 19221629
[No Abstract] [Full Text] [Related]
11. What do we need to learn to optimize the SLIT alternative?
Serra HM; Alignani DO; Passalacqua G; Canonica GW; Correa SG
Eur Ann Allergy Clin Immunol; 2006 May; 38(5):158-65. PubMed ID: 17058848
[TBL] [Abstract][Full Text] [Related]
12. Distribution of Langerhans cells and mast cells within the human oral mucosa: new application sites of allergens in sublingual immunotherapy?
Allam JP; Stojanovski G; Friedrichs N; Peng W; Bieber T; Wenzel J; Novak N
Allergy; 2008 Jun; 63(6):720-7. PubMed ID: 18445186
[TBL] [Abstract][Full Text] [Related]
13. Subcutaneous and sublingual immunotherapy and T regulatory cells: there is clinical relevance.
Ciprandi G; Morandi F; Olcese R; Silvestri M; Tosca MA
Clin Exp Allergy; 2010 Oct; 40(10):1578-9; author reply 1579-80. PubMed ID: 20937063
[No Abstract] [Full Text] [Related]
14. Basic science for the clinician: Mechanisms of sublingual and subcutaneous immunotherapy.
Lawrence MG; Steinke JW; Borish L
Ann Allergy Asthma Immunol; 2016 Aug; 117(2):138-42. PubMed ID: 27499541
[TBL] [Abstract][Full Text] [Related]
15. Mucosal dendritic cells in allergy and immunotherapy.
Novak N; Allam JP
Allergy; 2011 Jul; 66 Suppl 95():22-4. PubMed ID: 21668846
[TBL] [Abstract][Full Text] [Related]
16. [The mechanisms of allergen-specific immunotherapy more clear].
Rak S
Lakartidningen; 2008 Jun 25-Jul 1; 105(26-27):1935-7. PubMed ID: 18681375
[No Abstract] [Full Text] [Related]
17. Subcutaneous allergen immunotherapy restores human dendritic cell innate immune function.
Tversky JR; Bieneman AP; Chichester KL; Hamilton RG; Schroeder JT
Clin Exp Allergy; 2010 Jan; 40(1):94-102. PubMed ID: 20205698
[TBL] [Abstract][Full Text] [Related]
18. Effect of one-year subcutaneous and sublingual immunotherapy on clinical and laboratory parameters in children with rhinitis and asthma: a randomized, placebo-controlled, double-blind, double-dummy study.
Yukselen A; Kendirli SG; Yilmaz M; Altintas DU; Karakoc GB
Int Arch Allergy Immunol; 2012; 157(3):288-98. PubMed ID: 22041501
[TBL] [Abstract][Full Text] [Related]
19. Sublingual immunotherapy: from safety to mechanism of action.
Marcucci F; Sensi L; Allocca G; Chiarello F; Palleri P; Ugolini E; Di Rienzo A; Castellani S; Incorvaia C; Di Cara G; Puccinelli P; Frati F
Eur Ann Allergy Clin Immunol; 2007 Mar; 39(3):101-3. PubMed ID: 17465282
[TBL] [Abstract][Full Text] [Related]
20. The history of sublingual immunotherapy.
Pajno GB; Barberi S
Int J Immunopathol Pharmacol; 2009; 22(4 Suppl):1-3. PubMed ID: 19944001
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
